US Senate Delays Federal Hemp THC Ban Until Dec. 11

The U.S. Senate has inserted a provision into a bipartisan continuing resolution that postpones most federal restrictions on hemp‑derived THC products from the originally scheduled November 12 deadline to December 11. The delay applies to non‑synthetic hemp products such as beverages and full‑spectrum CBD items, while synthetic cannabinoids remain prohibited on November 12. Senate Appropriations Committee Chair Susan Collins and Vice‑Chair Patty Murray released the text of the Continuing Appropriations and Extensions Act, 2027, giving the industry a brief breathing room to seek a longer‑term regulatory solution.

Legislators are also advancing a separate bipartisan effort, the Lawful Hemp Protection Act introduced by Rep. Andy Barr (R‑KY) and Rep. Angie Craig (D‑MN), which would replace the ban with a federal regulatory framework setting potency limits, labeling standards and domestic production requirements. The proposal has garnered support from the Hemp Beverage Alliance and the U.S. Hemp Roundtable.

In Texas, three hemp‑industry participants have filed a lawsuit alleging that the state’s recent classification of most hemp‑derived THC products as illegal violates the 2018 Farm Bill’s interstate commerce protections. The case seeks to block the state ban and highlights the broader legal challenges surrounding hemp regulation across the United States.